The Patent Finder

Eyegene Inc.

Also on record
Records under this name other than the patents Eyegene Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 8 of 8 · Back to Eyegene Inc.

PatentTitleStatus Expires Confidence
US 7,897,739Method for diagnosing diabetic retinopathy by single nucleotide polymorphism, DNA fragment thereof, and primer thereof
Term ended
Term ended Dec 28, 2025 · From the USPTO record
Term endedTerm ended Dec 28, 2025From the USPTO record
US 9,572,877Vaccine for inducing an improved immune reaction
Lapsed on the fee record
Ended Feb 21, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 21, 2025From the USPTO record
US 10,918,709Immune modulator and vaccine composition containing the same
Lapsed on the fee record
Ended Feb 16, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 16, 2025From the USPTO record
US 9,566,323Vaccine for cervical cancer
Lapsed on the fee record
Ended Feb 14, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 14, 2025From the USPTO record
US 8,372,811Composition for treating retinopathy or glaucoma comprising thrombin derived peptides
Lapsed on the fee record
Ended Feb 12, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 12, 2025From the USPTO record
US 7,507,802Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides
Term ended
Term ended Dec 12, 2023 · From the USPTO record
Term endedTerm ended Dec 12, 2023From the USPTO record
US 8,883,987Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides
Term ended
Ended no later than Sep 26, 2022 · From the USPTO record
Term endedEnded no later than Sep 26, 2022From the USPTO record
US 9,101,581Method for treating vascular-related disease
Surrendered on reissue
Surrendered on reissue Jun 2, 2020 · From the USPTO record
Surrendered on reissueSurrendered on reissue Jun 2, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited